FDA Recalls Finder

FDA expands use of endovascular graft to treat aortic tears
13 January 2012, 2:59 pm

The U.S. Food and Drug Administration today expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection). (MB)

Source: Food and Drug Administration--Press Releases